Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Torsten Zuberbier, Amir Hamzah Abdul Latiff, Mohamed Abuzakouk et al. · Allergy · 2021 · 1.1K citations · Full text

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

Marcus Maurer, Karin Rosén, Hsin-Ju Hsieh et al. · New England Journal of Medicine · 2013 · 1K citations · Full text

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

Allen P. Kaplan, Dennis K. Ledford, Mark Ashby et al. · Journal of Allergy and Clinical Immunology · 2013 · 552 citations

Symptomatic Chronic, Allergy Medicine, Clinical Dermatology +5

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

Sarbjit S. Saini, Carsten Bindslev‐Jensen, Marcus Maurer et al. · Journal of Investigative Dermatology · 2014 · 449 citations · Full text

The impact of chronic urticaria on the quality of life

Colm P. O’Donnell, J. SIMPSON, Myfanwy Morgan · British Journal of Dermatology · 1997 · 341 citations